Curanex Pharmaceuticals Files 8-K
Ticker: CURX · Form: 8-K · Filed: Apr 2, 2026 · CIK: 0002025942
| Field | Detail |
|---|---|
| Company | Curanex Pharmaceuticals Inc (CURX) |
| Form Type | 8-K |
| Filed Date | Apr 2, 2026 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure, financial-exhibits
TL;DR
Curanex Pharma dropped an 8-K, check the exhibits for the latest news.
AI Summary
Curanex Pharmaceuticals Inc. filed an 8-K on April 2, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). The filing includes an 8-K form, an exhibit (EX-99.1), and associated XBRL data. The company's mailing and business address is 2 Jericho Plaza, Suite 101B, Jericho, NY 11753.
Why It Matters
This filing indicates that Curanex Pharmaceuticals is making disclosures and providing financial exhibits, which could contain important updates for investors regarding the company's status.
Risk Assessment
Risk Level: low — This is a routine filing for an 8-K and does not appear to contain any immediate material adverse information.
Key Numbers
- 0002025942 — CIK Number (Identifies Curanex Pharmaceuticals Inc. in SEC filings.)
- 2026-04-02 — Filing Date (Date Curanex Pharmaceuticals Inc. filed this 8-K report.)
Key Players & Entities
- Curanex Pharmaceuticals Inc. (company) — Filer
- 0002025942 (company) — CIK Number
- 2026-04-02 (date) — Filing Date
- 2 Jericho Plaza, Suite 101B, Jericho, NY 11753 (address) — Mailing and Business Address
FAQ
What specific information is disclosed under Regulation FD?
The filing indicates Item 7.01 (Regulation FD Disclosure) but does not detail the specific information disclosed within this 8-K document itself; it would be found in the attached exhibits.
What types of financial statements or exhibits are included?
The filing lists 'Financial Statements and Exhibits' under Item 9.01 and includes EX-99.1 as an exhibit, along with XBRL data.
What is the company's CIK number?
The CIK number for Curanex Pharmaceuticals Inc. is 0002025942.
Where is Curanex Pharmaceuticals Inc. located?
The company's mailing and business address is 2 Jericho Plaza, Suite 101B, Jericho, NY 11753.
What is the filing date of this 8-K report?
The 8-K report was filed on April 2, 2026.
Filing Stats: 528 words · 2 min read · ~2 pages · Grade level 12.4 · Accepted 2026-04-02 08:20:25
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share CURX The Nasdaq Capital M
Filing Documents
- form8-k.htm (8-K) — 38KB
- ex99-1.htm (EX-99.1) — 13KB
- ex99-1_001.jpg (GRAPHIC) — 3KB
- 0001493152-26-014815.txt ( ) — 222KB
- curx-20260402.xsd (EX-101.SCH) — 3KB
- curx-20260402_lab.xml (EX-101.LAB) — 33KB
- curx-20260402_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Curanex Pharmaceuticals Inc Date: April 2, 2026 By: /s/ Jun Liu Name: Jun Liu Title: Chief Executive Officer